- Feb 6, 2022
- 1 min
USFDA Guidance on Premarket Review of Combination Products
- Feb 6, 2022
- 1 min
Swissmedic Guidance on Renewals, Variations & Extensions
- Feb 6, 2022
- 2 min
Ireland's guidance on New Application & Variations, Registartion Requirements,
- Feb 6, 2022
- 1 min
Guidance on Revising ANDA Labeling Following Revision of the RLD Labeling
- Jan 27, 2022
- 1 min
Patients’ Experiences & Engagements Medical Device Guidances - USFDA
- Jan 27, 2022
- 1 min
USFDA Guidance update on Generic Drug Application Submissions, Labeling, and Review
- Jan 23, 2022
- 1 min
Electronic Application Form and Cover Letter Tool - UK MHRA
- Jan 23, 2022
- 2 min
CHINA’S NMPA: Development Guideline of Drug-Device Combinations
- Jan 23, 2022
- 1 min
India's National Pharmaceutical Pricing Authority (NPPA) -Study on global drug pricing policies
- Jan 16, 2022
- 1 min
EMA Guidance for Applicants seeking Scientific Advice and Protocol Assistance
- Jan 16, 2022
- 1 min
UK Guidance on Clinical Trials: How to Apply for Authorization
- Jan 16, 2022
- 1 min
Guidelines for Biowaiver -Saudi Food & Drug Authority SFDA
- Jan 7, 2022
- 1 min
Regulating Medical Devices & Place on The Market – UK